Global Retirement Partners LLC Makes New $3.32 Million Investment in Stryker Corporation $SYK

Global Retirement Partners LLC acquired a new stake in shares of Stryker Corporation (NYSE:SYK - Free Report) during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund acquired 10,532 shares of the medical technology company's stock, valued at approximately $3,316,000.

Other large investors also recently modified their holdings of the company. Godfrey Financial Associates Inc. acquired a new stake in Stryker in the 4th quarter valued at $26,000. Sankala Group LLC bought a new stake in Stryker in the fourth quarter valued at $26,000. United Financial Planning Group LLC acquired a new position in Stryker during the third quarter worth $27,000. Atlas Capital Advisors Inc. acquired a new position in Stryker during the fourth quarter worth $27,000. Finally, DJE Kapital AG bought a new position in shares of Stryker during the fourth quarter valued at $28,000. 77.09% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on SYK. Wall Street Zen upgraded shares of Stryker from a "hold" rating to a "buy" rating in a research note on Saturday, August 8th. Citizens Jmp cut their price target on shares of Stryker from $440.00 to $400.00 and set a "market outperform" rating for the company in a report on Monday, August 3rd. BMO Capital Markets began coverage on shares of Stryker in a research report on Wednesday, July 8th. They issued an "outperform" rating and a $369.00 price target on the stock. Citigroup reaffirmed a "buy" rating on shares of Stryker in a research note on Thursday. Finally, Leerink Partners dropped their price objective on shares of Stryker from $410.00 to $407.00 and set an "outperform" rating for the company in a report on Friday, June 5th. One research analyst has rated the stock with a Strong Buy rating, seventeen have given a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Stryker currently has a consensus rating of "Moderate Buy" and a consensus target price of $386.28.

Insider Buying and Selling

In related news, VP Robert S. Fletcher sold 4,544 shares of the business's stock in a transaction that occurred on Thursday, May 28th. The shares were sold at an average price of $306.87, for a total value of $1,394,417.28. Following the completion of the transaction, the vice president owned 10,582 shares in the company, valued at $3,247,298.34. The trade was a 30.04% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Ronda E. Stryker sold 310,000 shares of the company's stock in a transaction on Tuesday, May 26th. The stock was sold at an average price of $312.23, for a total value of $96,791,300.00. Following the transaction, the director directly owned 1,924,880 shares in the company, valued at approximately $601,005,282.40. This represents a 13.87% decrease in their position. The SEC filing for this sale provides additional information. 4.60% of the stock is currently owned by corporate insiders.

Stryker Stock Performance

Shares of NYSE:SYK opened at $338.80 on Monday. Stryker Corporation has a twelve month low of $281.00 and a twelve month high of $396.86. The firm has a market cap of $129.95 billion, a PE ratio of 35.11, a price-to-earnings-growth ratio of 2.16 and a beta of 0.76. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The business has a fifty day moving average of $324.61 and a 200-day moving average of $333.40.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, July 30th. The medical technology company reported $3.69 earnings per share (EPS) for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a net margin of 14.43% and a return on equity of 23.63%. The business had revenue of $6.59 billion for the quarter, compared to the consensus estimate of $6.58 billion. During the same quarter in the prior year, the company earned $3.13 EPS. The firm's quarterly revenue was up 9.4% on a year-over-year basis. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. On average, equities research analysts predict that Stryker Corporation will post 15.02 EPS for the current fiscal year.

Stryker Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.0%. The ex-dividend date is Wednesday, September 30th. Stryker's dividend payout ratio is presently 36.48%.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons' offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Corporation (NYSE:SYK - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source